ClinConnect ClinConnect Logo
Search / Trial NCT01418469

Disturbances in BCAA Metabolism and the Effects of Feeding and Exercise in COPD

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Aug 16, 2011

Trial Information

Current as of April 24, 2025

Completed

Keywords

Copd Protein Metabolism Branched Chain Amino Acid Metabolism Exercise Protein Feeding

ClinConnect Summary

In this study we investigate whether milk based protein sources of BCAA (casein and whey proteins) are superior to soy protein in the stimulation of protein anabolism before, during and after cycle exercise in COPD and healthy elderly and young subjects, and whether adding BCAA to soy protein will increase protein anabolism in these subjects.

To investigate Leucine, Isoleucine and Valine metabolism during and after exercise in COPD and healthy subjects

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Irreversible chronic airflow limitation (FEV1 \<70% of predicted)
  • Clinically stable condition
  • Exclusion Criteria:
  • Oxygen supplementation
  • Respiratory tract infection or exacerbation of his disease at least 4 weeks prior to the study
  • Oral corticosteroids as maintenance medication
  • Other concomitant metabolic disease (ie malignancy, cardiac failure, recent surgery, severe endocrine, hepatic or renal disorder)

Trial Officials

Nicolaas EP Deutz, MD, PhD

Principal Investigator

University of Arkansas

About Maastricht University Medical Center

Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.

Locations

Maastricht, , Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials